255 related articles for article (PubMed ID: 12008922)
1. Antigenic relatedness between Burkholderia pseudomallei and Burkholderia mallei.
Anuntagool N; Sirisinha S
Microbiol Immunol; 2002; 46(3):143-50. PubMed ID: 12008922
[TBL] [Abstract][Full Text] [Related]
2. Development of mouse hybridomas for production of monoclonal antibodies specific to Burkholderia mallei and Burkholderia pseudomallei.
Feng SH; Tsai S; Rodriguez J; Newsome T; Emanuel P; Lo SC
Hybridoma (Larchmt); 2006 Aug; 25(4):193-201. PubMed ID: 16934015
[TBL] [Abstract][Full Text] [Related]
3. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei.
Kim HS; Tsai S; Zou N; Lo SC; Wear DJ; Izadjoo MJ
J Immunol Methods; 2011 Feb; 365(1-2):101-9. PubMed ID: 21172353
[TBL] [Abstract][Full Text] [Related]
4. [Immunobiological properties of Burkholderia pseudomallei and Burkholderia mallei capsular substances].
Popov SF; Tikhonov NG; Piven' NN; Avrorova IV; Viktorov DV; Kurilov VIa
Zh Mikrobiol Epidemiol Immunobiol; 2002; (6):60-4. PubMed ID: 12506631
[TBL] [Abstract][Full Text] [Related]
5. Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies.
Parthasarathy N; DeShazer D; England M; Waag DM
Diagn Microbiol Infect Dis; 2006 Nov; 56(3):329-32. PubMed ID: 16765554
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharides from Different
Sengyee S; Yoon SH; West TE; Ernst RK; Chantratita N
Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31548320
[TBL] [Abstract][Full Text] [Related]
7. Relationship between antigenicity and pathogenicity for Burkholderia pseudomallei and Burkholderia mallei revealed by a large panel of mouse MAbs.
Zou N; Tsai S; Feng SH; Newsome T; Kim HY; Li B; Zhang S; Lo SC
Hybridoma (Larchmt); 2008 Aug; 27(4):231-40. PubMed ID: 18707541
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a latex agglutination assay for the identification of Burkholderia pseudomallei and Burkholderia mallei.
Duval BD; Elrod MG; Gee JE; Chantratita N; Tandhavanant S; Limmathurotsakul D; Hoffmaster AR
Am J Trop Med Hyg; 2014 Jun; 90(6):1043-6. PubMed ID: 24710616
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.
Moustafa DA; Scarff JM; Garcia PP; Cassidy SK; DiGiandomenico A; Waag DM; Inzana TJ; Goldberg JB
PLoS One; 2015; 10(7):e0132032. PubMed ID: 26148026
[TBL] [Abstract][Full Text] [Related]
10. Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei.
Godoy D; Randle G; Simpson AJ; Aanensen DM; Pitt TL; Kinoshita R; Spratt BG
J Clin Microbiol; 2003 May; 41(5):2068-79. PubMed ID: 12734250
[TBL] [Abstract][Full Text] [Related]
11. Rapid multiplex immunofluorescent assay to detect antibodies against Burkholderia pseudomallei and taxonomically closely related nonfermenters.
Iihara H; Niwa T; Shah MM; Nhung PH; Song SX; Hayashi M; Ohkusa K; Itoh Y; Makino S; Ezaki T
Jpn J Infect Dis; 2007 Jul; 60(4):230-4. PubMed ID: 17642542
[TBL] [Abstract][Full Text] [Related]
12. Development of Immunoassays for
Nualnoi T; Norris MH; Tuanyok A; Brett PJ; Burtnick MN; Keim PS; Settles EW; Allender CJ; AuCoin DP
Am J Trop Med Hyg; 2017 Feb; 96(2):358-367. PubMed ID: 27994103
[No Abstract] [Full Text] [Related]
13. In Vitro and In Vivo studies of monoclonal antibodies with prominent bactericidal activity against Burkholderia pseudomallei and Burkholderia mallei.
Zhang S; Feng SH; Li B; Kim HY; Rodriguez J; Tsai S; Lo SC
Clin Vaccine Immunol; 2011 May; 18(5):825-34. PubMed ID: 21450976
[TBL] [Abstract][Full Text] [Related]
14. Production and characterization of chimeric monoclonal antibodies against Burkholderia pseudomallei and B. mallei using the DHFR expression system.
Kim HY; Tsai S; Lo SC; Wear DJ; Izadjoo MJ
PLoS One; 2011 May; 6(5):e19867. PubMed ID: 21573027
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of an exopolysaccharide of Burkholderia (Pseudomonas) pseudomallei.
Steinmetz I; Rohde M; Brenneke B
Infect Immun; 1995 Oct; 63(10):3959-65. PubMed ID: 7558305
[TBL] [Abstract][Full Text] [Related]
16. Molecular and physical characterization of Burkholderia mallei O antigens.
Burtnick MN; Brett PJ; Woods DE
J Bacteriol; 2002 Feb; 184(3):849-52. PubMed ID: 11790757
[TBL] [Abstract][Full Text] [Related]
17. Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins.
Jones SM; Ellis JF; Russell P; Griffin KF; Oyston PCF
J Med Microbiol; 2002 Dec; 51(12):1055-1062. PubMed ID: 12466403
[TBL] [Abstract][Full Text] [Related]
18. Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei.
Gee JE; Sacchi CT; Glass MB; De BK; Weyant RS; Levett PN; Whitney AM; Hoffmaster AR; Popovic T
J Clin Microbiol; 2003 Oct; 41(10):4647-54. PubMed ID: 14532197
[TBL] [Abstract][Full Text] [Related]
19. Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders.
Burtnick MN; Heiss C; Roberts RA; Schweizer HP; Azadi P; Brett PJ
Front Cell Infect Microbiol; 2012; 2():108. PubMed ID: 22912938
[TBL] [Abstract][Full Text] [Related]
20. [Study of extracellular antigens by immunodiffusion methods in differentiation of pathogenic burkholderiae].
Budchenko AA; Mazurova IIu; Iliukhin VI
Zh Mikrobiol Epidemiol Immunobiol; 2012; (1):54-60. PubMed ID: 22442972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
